uracil has been researched along with Koch's Disease in 10 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| "The upp (Rv3309c)-encoded uracil phosphoribosyltransferase from Mycobacterium tuberculosis (MtUPRT) converts uracil and 5-phosphoribosyl-α-1-pyrophosphate into pyrophosphate and uridine 5΄-monophosphate, the precursor of all pyrimidine nucleotides." | 7.85 | Analysis of uracil phosphoribosyltransferase expression in Mycobacterium tuberculosis and evaluation of upp knockout strain in infected mice. ( Basso, LA; Campos, MM; Grzegorzewicz, AE; Jackson, M; Jones, V; Pham, H; Rodrigues-Junior, VD; Santos, DS; Villela, AD, 2017) |
| "The upp (Rv3309c)-encoded uracil phosphoribosyltransferase from Mycobacterium tuberculosis (MtUPRT) converts uracil and 5-phosphoribosyl-α-1-pyrophosphate into pyrophosphate and uridine 5΄-monophosphate, the precursor of all pyrimidine nucleotides." | 3.85 | Analysis of uracil phosphoribosyltransferase expression in Mycobacterium tuberculosis and evaluation of upp knockout strain in infected mice. ( Basso, LA; Campos, MM; Grzegorzewicz, AE; Jackson, M; Jones, V; Pham, H; Rodrigues-Junior, VD; Santos, DS; Villela, AD, 2017) |
| "Here we treated M." | 1.62 | Functional inactivation of pulmonary MAIT cells following 5-OP-RU treatment of non-human primates. ( Arlehamn, CSL; Barber, DL; Barry Iii, CE; Dorosky, DE; Fleegle, JD; Freeman, GJ; Gomez, F; Kauffman, KD; Lora, NE; Namasivayam, S; Oh, S; Sakai, S; Sette, A; Sher, A; Via, LE, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakai, S | 1 |
| Lora, NE | 1 |
| Kauffman, KD | 1 |
| Dorosky, DE | 1 |
| Oh, S | 1 |
| Namasivayam, S | 1 |
| Gomez, F | 1 |
| Fleegle, JD | 1 |
| Arlehamn, CSL | 1 |
| Sette, A | 1 |
| Sher, A | 1 |
| Freeman, GJ | 1 |
| Via, LE | 1 |
| Barry Iii, CE | 1 |
| Barber, DL | 1 |
| Wang, Y | 2 |
| Liu, D | 1 |
| Deng, J | 1 |
| Xu, J | 1 |
| Ye, C | 1 |
| Matyugina, E | 1 |
| Novikov, M | 1 |
| Babkov, D | 1 |
| Ozerov, A | 1 |
| Chernousova, L | 1 |
| Andreevskaya, S | 1 |
| Smirnova, T | 1 |
| Karpenko, I | 1 |
| Chizhov, A | 1 |
| Murthu, P | 1 |
| Lutz, S | 1 |
| Kochetkov, S | 1 |
| Seley-Radtke, KL | 1 |
| Khandazhinskaya, AL | 1 |
| Villela, AD | 1 |
| Pham, H | 1 |
| Jones, V | 1 |
| Grzegorzewicz, AE | 1 |
| Rodrigues-Junior, VD | 1 |
| Campos, MM | 1 |
| Basso, LA | 1 |
| Jackson, M | 1 |
| Santos, DS | 1 |
| Srivastav, NC | 1 |
| Rai, D | 1 |
| Tse, C | 1 |
| Agrawal, B | 1 |
| Kunimoto, DY | 1 |
| Kumar, R | 1 |
| Stach, JL | 1 |
| Gros, P | 1 |
| Forget, A | 1 |
| Skamene, E | 1 |
| Zabaleta, J | 1 |
| Arias, M | 1 |
| Maya, JR | 1 |
| García, LF | 1 |
| Nau, GJ | 1 |
| Liaw, L | 1 |
| Chupp, GL | 1 |
| Berman, JS | 1 |
| Hogan, BL | 1 |
| Young, RA | 1 |
| Zabolotnykh, NV | 1 |
| Aleksandrova, AE | 1 |
| Rook, GA | 1 |
| Champion, BR | 1 |
| Steele, J | 1 |
| Varey, AM | 1 |
| Stanford, JL | 1 |
10 other studies available for uracil and Koch's Disease
| Article | Year |
|---|---|
Functional inactivation of pulmonary MAIT cells following 5-OP-RU treatment of non-human primates.
Topics: Animals; Biomarkers; Cytokines; Disease Management; Disease Susceptibility; Host-Pathogen Interactio | 2021 |
Loop-mediated isothermal amplification using self-avoiding molecular recognition systems and antarctic thermal sensitive uracil-DNA-glycosylase for detection of nucleic acid with prevention of carryover contamination.
Topics: Biosensing Techniques; DNA; DNA Primers; Humans; Mycobacterium tuberculosis; Nucleic Acid Amplificat | 2017 |
5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Line, Tumor; Chlorocebus aethiops; Drug Design; Enzyme Inhibito | 2015 |
Analysis of uracil phosphoribosyltransferase expression in Mycobacterium tuberculosis and evaluation of upp knockout strain in infected mice.
Topics: Animals; Bacterial Proteins; Disease Models, Animal; Gene Expression; Gene Knockout Techniques; Mice | 2017 |
Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2'-deoxynucleoside analogues using in vitro and in vivo models.
Topics: Alkynes; Animals; Antitubercular Agents; Cell Line, Tumor; Deoxycytidine; Deoxyribonucleosides; Huma | 2010 |
Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG).
Topics: Animals; Chromosome Mapping; Dose-Response Relationship, Immunologic; Female; Immunity, Innate; Kine | 1984 |
Diminished adherence and/or ingestion of virulent Mycobacterium tuberculosis by monocyte-derived macrophages from patients with tuberculosis.
Topics: Bacterial Adhesion; Cells, Cultured; Colony Count, Microbial; Culture Media, Serum-Free; Flow Cytome | 1998 |
Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin.
Topics: Animals; Cytokines; Granuloma; Hyaluronan Receptors; Interferon-gamma; Macrophages; Mice; Mycobacter | 1999 |
[Efficacy of immunotropic drugs in experimental tuberculosis].
Topics: Animals; Drug Therapy, Combination; Guinea Pigs; Isoniazid; Levamisole; Mice; Thymus Hormones; Tuber | 1985 |
I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages.
Topics: Animals; Cells, Cultured; Female; Histocompatibility Antigens Class II; Macrophage Activation; Major | 1985 |